NIST Allocates Over $3 Million to Small Businesses Advancing AI, Biotechnology, Semiconductors, Quantum and More
NIST's SBIR grants signal US small-business R&D priorities in AI-adjacent domains, but carry no immediate APS governance implications.
Key points
- NIST allocates $3.19 million across eight US small businesses under its Phase II SBIR program.
- AI features in two projects: biopharmaceutical cell-culture monitoring and an OT cybersecurity compliance scoring tool.
- Limited direct relevance to Australian federal agencies - US domestic R&D funding announcement included for context only.
View original source
Copied.
"NIST Allocates Over $3 Million to Small Businesses Advancing AI, Biotechnology, Semiconductors, Quantum and More"
Source: NIST Information Technology RSS
Published: 10 February 2026
URL: https://www.nist.gov/news-events/news/2026/02/nist-allocates-over-3-million-small-businesses-advancing-ai-biotechnology
NIST has announced $3.19 million in Phase II Small Business Innovation Research grants to eight US companies across AI, biotechnology, semiconductors, quantum, and environmental monitoring. Of the eight projects, two involve AI: a machine-learning-assisted hyperspectral imaging system for biopharmaceutical manufacturing, and an AI-powered operational technology cybersecurity compliance tool using NIST and CISA data sources. Remaining projects cover medical imaging phantoms, optical calibration, quantum photon sources, PFAS wearable monitoring, and residential energy profiling. These are 24-month prototyping grants with no direct Australian regulatory or policy parallel.
Retrieved from SIMS, 18 July 2026.